Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, November 18, 2025
BioDuro announced the launch of a new Business Unit (BU) dedicated to advancing peptide drug discovery and development for its global biopharma partners, underscoring the company’s commitment to strengthening its peptide technology platform to meet ...
read more
BioDuro, LLC, a global contract research organization (CRO) focused on fully outsourced turnkey discovery and development services in Oncology, Inflammatory Disease, Metabolism and CNS for pharmaceutical partners, has announced the formal launch of ...
read more
BioDuro announced the acquisition of Molecular Response and its translational oncology research platform, including its biobank of more than 100,000 viable tumor specimens.
read more
Monday, December 09, 2019
BioDuro has announced the appointment of Kent Payne, Ph.D., as President of its CMC Global Solutions business unit.
read more
BioDuro announced it has established a joint venture with Cenra API Solutions to add significant commercial-scale active pharmaceutical ingredient (API) manufacturing capacity at Cenra's campus in Taipei, Taiwan, to BioDuro's global network.
read more
This collaboration brings together Atombeat’s in silico modeling expertise, AI-accelerated & data-driven design platform with BioDuro’s expertise in discovery chemistry, biology and DMPK to accelerate the development of next-generation peptides.
read more
Wednesday, March 30, 2016
Biodextris Inc. has announced its suite of services and commitment to building a full service contract organization. The new contract research organization (CRO) provides analytical and process development services for vaccines and biologics ...
read more
Tuesday, February 14, 2023
Biodextris Inc., a subsidiary of Clean Biologics SAS, announced the development of a new industrial-scale vaccine and biologics development, manufacturing and packaging plant (CDMO).
read more
Thursday, December 03, 2015
BioDelivery Sciences International has appointed Joseph (Jody) M. Lockhart as Vice President of Manufacturing and Supply Chain.
read more
Biocytogen Pharmaceuticals announced that its Project Integrum has completed 2 core milestones, and its antibody business is now entering a new stage of rapid growth.
read more
Tuesday, December 08, 2020
Beijing Biocytogen, Biocytogen Boston Corp, announced they have reached an agreement with Xencor, Inc., for the licensing of Biocytogen's fully human antibody RenMab/RenLite Mouse platform.
read more
Biocytogen Pharmaceuticals announced the grand opening of a new 37,000 square foot facility in Waltham, MA for its US-based subsidiary, Biocytogen Boston Corporation.
read more
Monday, November 29, 2021
BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified manufacturing of sterile drug products in vials and syringes, today announced that Nykode Therapeutics AS...
read more
BioConnection, an independent CDMO based in Oss, The Netherlands announced the completion of a new capital raising led by the European investment company Gimv, and supported by existing shareholders Pharming Group N.V., Mibiton and BioConnection’s ...
read more
Wednesday, September 25, 2019
Biocon Biologics has acquired R&D capital assets for a 60,000 sq. ft ‘bench to pilot scale’ Biologics research facility at TICEL Bio Park in Chennai from Pfizer Healthcare India.
read more